ebulization for fiberoptic intubatio
Phase 4
- Conditions
- Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified
- Registration Number
- CTRI/2023/07/054986
- Lead Sponsor
- M D M Hospital Dr S N Medical College Jodhpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American Society of Anesthesiologists (ASA) physical status of Iâ??II, and body mass index (BMI) <=25 kg/cm2 with anticipated difficult airway will be posted for elective surgery under general anesthesia included in the study
Exclusion Criteria
a. Patient refusal
b. Patients with a history of allergy to the local anesthetic or Dexmedetomidine
c. Patients with nasal infection or complete obstruction
d. Pregnancy (confirmed by history and card test) and lactation
e. Patients with coagulation dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the patients comfort & compliance for intubation in terms of COUGH SCORE using dexmedetomidine as an adjuvant to lignocaine for nebulization & lignocaine alone for nebulization in patients undergoing awake fiberoptic intubation.Timepoint: 1 hour
- Secondary Outcome Measures
Name Time Method 1. RAMSAY SEDATION SCORE <br/ ><br>2. POST INTUBATION SCORE <br/ ><br>3. The mean time to intubation <br/ ><br>4. Hemodynamic parameters <br/ ><br>5. Patient satisfactionTimepoint: 24 hours